41.83 USD
↗ 0.54 (1.31%)AT CLOSE (11:59 AM EDT)
Indivior Pharmaceuticals, Inc. Common Stock
INDVNASDAQ • USD
41.90
↗ 0.07 (0.17%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
41.90
↗ 0.07 (0.17%)
Market: CLOSED
INDV is currently priced at $41.83. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. INDV is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jun 26, 2026.
Open?$41.30
High?$42.81
Low?$41.01
Prev. Close?$41.29
Volume?5.6M
Avg. Volume?1.9M
VWAP?$41.95
Rel. Volume?3.01x
Bid / Ask
Bid?$35.56 × 100
Ask?$51.30 × 100
Spread?$15.74
Midpoint?$43.43
Valuation & Ratios
Market Cap?4.9B
Shares Out?121.9M
Float?114.6M
Float %?91.8%
P/E Ratio?19.70
P/B Ratio?-34.34
EPS?$2.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Employees
838
Market Cap
4.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-12-24
Address
10710 MIDLOTHIAN TURNPIKE
NORTH CHESTERFIELD, VA 23235
Phone: 804-379-1090
NORTH CHESTERFIELD, VA 23235
Phone: 804-379-1090
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?89
Momentum?73
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?3.77Safe
Confidence?49%Low
Short InterestHigh
Short % of Float?10.34%High
Short Interest?11.9M
Days to Cover?7.1
Free Float114.6M
Avg Daily Volume1.7M
Settlement Date2026-06-15
Financial Health
Current Ratio?0.86Weak
Quick Ratio?0.66Weak
Cash Ratio?0.22Low
Debt/Equity?-3.38Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score73/100
P/E?19.7FAIR▾
Peers100
S&P66
P/B?-34.34CHEAP▾
S&P97
P/S?3.83FAIR▾
Peers100
S&P40
P/FCF?N/A▾
EV/EBITDA?15.4FAIR▾
Peers100
S&P47
EV/Sales?4.07FAIR▾
Peers100
S&P46
Returns & Efficiency
ROE?-174.3%WEAK▾
S&P3
ROA?21.0%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$-193000000
Enterprise Value?$5.3B
Fundamentals ratios updated end of day